ResourceClinical Diagnostics
Larger spheres equate to higher sensitivity: New Estapor IT 250 microspheres for LTIA
10 Nov 2022This product brochure described the new IT 250 carboxyl-modified microspheres for Latex Turbidimetry (LTIA) from Merck. Uniquely developed for LTIA applications, the IT 250 microspheres exhibit key benefits making them an ideal choice for diagnostic developers looking for a microsphere that satisfies their requirements.
Links
Tags
Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Assay DevelopmentThe process of proving an assay to be sensitive with respect to the target is known as assay development. The assay should be able to characterize novel compounds and measure the potency of these compounds against a validated biological target.Molecular DiagnosticsMolecular diagnostics use an individual’s genetic code and gene expression to diagnose and monitor diseases. The technique is used increasingly in the field of infectious diseases and oncology, as well as areas such as coagulation, HLA typing and pharmacogenomics. Molecular diagnostics plays a pivotal role in personalized medicine.
